本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Krystal Biotech Inc.

153.25
+1.350.89%
盘后153.250.00000.00%19:32 EDT
成交量:26.54万
成交额:4,064.30万
市值:44.29亿
市盈率:36.88
高:154.27
开:153.28
低:151.26
收:151.90
数据加载中...
2024/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/06

重要事件披露

Form 8-K - Current report
2023/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities